2nd NCRI AML Academy
Diagnosis and Management of Adult AML:
where are we in 2020?
8-9 October 2020
Sessions will cover the management of older (and younger) adults with AML, emerging drug and antibody targeted therapies, genomics in diagnosis and management, novel therapeutic strategies in relapsed AML, the David Grimwade memorial lecture and a transplant roundtable (presented cases with panel discussion). In the afternoon, the masterclasses will be based on management of relapsed AML and nursing and the day will end with a debate: DA is still the standard induction therapy for all fit AML patients in the UK.